Validation of the Cancer BioChip System as a 3D siRNA Screening Tool for Breast Cancer Targets


Genomic studies have revealed that breast cancer consists of a complex biological process with patient-specific genetic variations, revealing the need for individualized cancer diagnostic testing and selection of patient-specific optimal therapies. One of the bottlenecks in translation of genomic breakthroughs to the clinic is the lack of functional genomic… (More)
DOI: 10.1371/journal.pone.0046086